Just to clarify: I’m not suggesting the DCVax-L decision is tied to the new RWD guidance — in fact, I don’t think it is
hahahaha ok Sherlock sure the pending MHRA ECA/RWD that can also be used without IPD guideline has ABSOLUTELY NOTHING to do with the DCVAXL application based on ECA without IPD now being in record review timeline waiting for something (boy ooh boy what could that be Watson) hahahahaha hihihihi. Another reason I do not take anything you say seriously. You and your buddy, ATL are so thick in the cult that you would not recognize reality if it hits you in the face.
Market Data 
Markets 
AI
